CARNEY LLOYD 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jan 31, 2023
Insider Transaction Report
Form 4
CARNEY LLOYD
Director
Transactions
- Sale
Common Stock
2023-01-30$320.70/sh−1,000$320,700→ 4,474 total - Sale
Common Stock
2023-01-30$320.08/sh−1,376$440,430→ 5,474 total - Sale
Common Stock
2023-01-30$321.84/sh−324$104,276→ 4,150 total
Footnotes (5)
- [F1]Transaction made pursuant to Mr. Carney's company approved trading plan under Rule 10b5-1.
- [F2]Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $320.08 (range $319.40 to $320.38).
- [F4]Open market sales reported on this line occurred at a weighted average price of $320.70 (range $320.43 to $321.31).
- [F5]Open market sales reported on this line occurred at a weighted average price of $321.84 (range $321.54 to $322.23).